Cocrystal Pharma (COCP) Cash from Investing Activities (2010 - 2024)
Cocrystal Pharma (COCP) posted Cash from Investing Activities of -$8000.0 for Q1 2024, up 86.44% sequentially from -$59000.0 in Q4 2023, and up 82.22% YoY from -$4390.2 in Q2 2023.
Cocrystal Pharma (COCP) Cash from Investing Activities (2010 - 2024) Analysis & Trends
Cocrystal Pharma has reported Cash from Investing Activities for 14 years, with the latest figure at -$8000.0 in Q1 2024.
- Quarterly Cash from Investing Activities rose 82.22% year-over-year to -$8000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was -$8000.0 (up 93.22% YoY) and the FY2025 annual result came in at -$12000.0, down 50.0% from the prior year.
- Cash from Investing Activities grew to -$8000.0 in Q1 2024 per COCP's latest filing, from -$59000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$1000.0 in Q4 2020 and troughed at -$127000.0 in Q2 2020.
- A 5-year average of -$33076.9 and a median of -$15000.0 in 2021 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2020 and 2021: Cash from Investing Activities tumbled 3075.0% in 2020, then jumped 88.19% in 2021.
- Over 5 years, Cash from Investing Activities stood at -$1000.0 in 2020, then tumbled by 700.0% to -$8000.0 in 2021, then slumped by 50.0% to -$12000.0 in 2022, then plunged by 391.67% to -$59000.0 in 2023, then surged by 86.44% to -$8000.0 in 2024.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$8000.0, -$59000.0, and -$14000.0 for Q1 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Mar 31, 2023 | -45,000.00 |
| Mar 31, 2023 | -45,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -15,000.00 |
| Jun 30, 2021 | -15,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |